Corticosteroids and chronic lung disease in extremely immature infants: A dilemma

Pediatric Pulmonology

Volumn 27, Issue SUPPL. 18, 1999, Pages 209-211

  Moriette, Guy ^a   Mikaeloff, Yann ^a   Jarreau, Pierre Henri ^a   Desfrère, Luc ^a  

^a Univ René Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; DEXAMETHASONE;

ANTIINFLAMMATORY ACTIVITY; CHRONIC LUNG DISEASE; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION; CHRONIC DISEASE; LUNG DISEASE; NEWBORN; PREMATURITY; REVIEW;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DEXAMETHASONE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LUNG DISEASES;

EID: 0032604330     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(1999)27:18+<209::AID-PPUL67>3.0.CO;2-M     Document Type: Conference Paper

References (12)

1. Rastogi A, Akintorin S, Bez M, Morales P, Pildes R. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics. 1996; 98:204-210.
2. Tapia J, Ramirez R, Cifuentes J, Fabres J, Hübner M, Bancalari A, Mercado M, Standen J, Escobar M. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr. 1998; 132:48-52.
3. Cummings J, D'Eugenio D, Gross S. A controlled trial of dexamethasone in pretenn infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989; 320:1505-1510.
4. Kari M, Heinonen K, Ikonen R, Koivisto M, Raivio K. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child. 1993; 68:566-569.
5. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics. 1995; 95:584-590.
6. Brozanski B, Jones J, Gilmour C, Balsan M, Vazquez R, Israel B, Newman B, Mimouni F, Guthrie R. Effects of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr. 1995; 126:769-776.
7. Ohlsson A, Calvert S, Hosking M, Shennan A. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr. 1992; 81:751-756.
8. Walti H, Moriette G, de Ajuriaguerra M, de Gamarra E, Relier J-P. La corticothérapie : un traitement trop dangereux de la dysplasie broncho-pulmonaire ? Ann Pédiatr. 1986; 33:29-32.
9. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease. Pediatrics. 1991; 88: 421-427.
10. Halliday H. A review of postnatal corticosteroids for treatment and prevention of chrome lung disease in the preterm infant. Prenat Neonat Med. 1997; 2:237-248.
11. Werner J, Sicard R, Hansen T, Solomon E, Cowett R, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr. 1992; 120: 286-291.
12. Yeh T, Torre J, Rastogi A, Anyebuno M, Pildes R. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990; 117:273-282.